The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Prophylactic treatment of gram‐positive and gram‐negative abdominal implant infections using locally delivered polyclonal antibodies
Abstract
The increasing clinical incidence and host risk of biomaterial‐centered infections, as well as the reduced effectiveness of clinically relevant antibiotics to treat such infections, provide compelling reasons to develop new approaches for treating implanted biomaterials in a surgical context. We describe the direct local delivery of polyclonal human antibodies to abdominal surgical implant sites to reduce infection severity and mortality in a lethal murine model of surgical implant‐centered peritoneal infection. Surgical implant‐centered peritonitis was produced in 180 female CF‐1 mice by the direct inoculation of surgical‐grade polypropylene mesh disks placed in the peritoneal cavity with lethal doses of either methicillin‐resistant Staphylococcus aureus (MRSA) or Pseudomonas aeruginosa. Mice randomly received a resorbable antibody delivery vehicle at the implant site: either a blank carboxymethylcellulose (CMC) aqueous gel or the same CMC gel containing 10 mg of pooled polyclonal human immunoglobulin G locally on the implant after infection, either alone or in combination with systemic doses of cefazolin or vancomycin antibiotics. Human antibodies were rapidly released (first‐order kinetics) from the gel carrier to both peritoneal fluids and serum in both infection scenarios. Inocula required for lethal infection were substantially reduced by surgery and the presence of the implant versus a closed lethal peritonitis model. Survival to 10 days with two different gram‐negative P. aeruginosa strains was significantly enhanced (p < 0.01) by the direct application of CMC gel containing antibodies alone to the surgical implant site. Human‐equivalent doses of systemic vancomycin provided a significantly improved benefit (p < 0.01) against lethal, implant‐centered, gram‐positive MRSA infection. However, locally delivered polyclonal human antibodies in combination with a range of systemic vancomycin doses against MRSA failed to improve host survival. Successful antibody therapy against gram‐negative, implant‐centered infections complements the clinically routine use of systemic antibiotics, providing a mechanism of protection independent of antibiotic resistance. © 2002 Wiley Periodicals, Inc. J Biomed Mater Res 60: 206–215, 2002
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Serum therapy revisited: animal models of infection and development of passive antibody therapy
Casadevall, A., & Scharff, M. D. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.8.1695 · Cited by 251
Cited by
Lebeaux, D., Ghigo, J.-M., & Beloin, C. (2014) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00013-14 · Cited by 1,318
Reducing implant-related infections: active release strategies
Hetrick, E. M., & Schoenfisch, M. H. (2006) · Chemical Society Reviews · doi:10.1039/b515219b · Cited by 1,201
Ribeiro, M., Monteiro, F. J., & Ferraz, M. P. (2012) · Biomatter · doi:10.4161/biom.22905 · Cited by 824
Nanobio Silver: Its Interactions with Peptides and Bacteria, and Its Uses in Medicine
Eckhardt, S., Brunetto, P. S., Gagnon, J., Priebe, M., Giese, B., & Fromm, K. M. (2013) · Chemical Reviews · doi:10.1021/cr300288v · Cited by 794
Superhydrophobic materials for biomedical applications
Falde, E. J., Yohe, S. T., Colson, Y. L., & Grinstaff, M. W. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.050 · Cited by 468
Metadata
- Authors
- Poelstra, K. A., Barekzi, N. A., Rediske, A. M., Felts, A. G., Slunt, J. B., & Grainger, D. W.
- Venue
- Journal of Biomedical Materials Research
- Publisher
- Wiley
- Published
- 2002-01-23
- Volume
- 60
- Issue
- 1
- Pages
- 206-215
- ISSN
- 0021-9304 (ISSN-L)
- 1097-4636
- OpenAlex
- W1984454581
- Cited by
- 158
- References
- 1
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.